Black Diamond Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.75
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.64
|
-0.60
|
0.04
|
6.25%
|
|
2022-06-30
|
-0.68
|
-0.63
|
0.05
|
7.35%
|
|
2022-03-31
|
-0.75
|
-0.70
|
0.05
|
6.67%
|
|
2021-12-31
|
-1.01
|
-0.71
|
0.30
|
29.70%
|
|
2021-09-30
|
-0.98
|
-0.97
|
0.01
|
1.02%
|
|
2021-06-30
|
-0.84
|
-0.95
|
-0.11
|
-13.10%
|
|
2021-03-31
|
-0.68
|
-0.84
|
-0.16
|
-23.53%
|
|
2020-12-31
|
-0.63
|
-0.63
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.93
|
|
2021-12-31
|
-3.47
|
|
2020-12-31
|
-2.05
|
|
2019-12-31
|
-5.12
|